Fisher & Paykel Healthcare Corporation Limited Stock: price and insider trades · Australia
Fisher & Paykel Healthcare Corporation Limited: what insiders have been doing
Fisher & Paykel Healthcare Corporation Limited has a thin disclosure history in our data (latest filing: 18 May 2026). New filings will appear here as soon as they are published. Source: insider filings from ASX. Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Analyst consensus: bullish or bearish?
Analysts rate Fisher & Paykel Healthcare Corporation Limited Buy (bullish), based on 8 analysts. Average price target: A$37.70.
Fundamental score
Ranked 8,494 of 26,911 companies
60.8
score / 100
Value35
Quality87
FCF yld2.0%
Earn yld2.0%
EV/EBITDA29.4x
ROE23%
Gross mgn64%
Net mgn20%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
A$36.50
Analyst consensus
8 analystsBuy
A$25.22Target A$37.70(+3%)A$44.66
Income statement
RevenueA$2.3B
Gross profitA$1.5B64% margin
EBITDAA$800.4M35% margin
Net incomeA$468.5M20.3% margin
Valuation
PER (trailing)56.2x
PER (forward)33.3x
P/Book12.3x
Beta0.89
Balance sheet & cash
Market capA$21.4B
Total debtA$146.1M
Free Cash FlowA$468M
Debt / Equity7%
Profitability & ownership
ROE23.4%
ROA14.7%
% insiders3.7%
% institutions38.2%
Last declaration on 18 May 2026
Declarations1 total
- ●Executives0ASX
1 of 1 declaration
About Fisher & Paykel Healthcare Corporation Limited
Fisher & Paykel Healthcare Corporation Limited is a New Zealand company that specializes in the design and manufacture of medical devices for respiratory and anesthesia applications. It is listed on the XASX market.
